Display options
Share it on

J Exp Med. 2022 Jan 03;219(1). doi: 10.1084/jem.20202343. Epub 2021 Nov 18.

Dependence on Bcl6 and Blimp1 drive distinct differentiation of murine memory and follicular helper CD4+ T cells.

The Journal of experimental medicine

Thomas Ciucci, Melanie S Vacchio, Ting Chen, Jia Nie, Laura B Chopp, Dorian B McGavern, Michael C Kelly, Rémy Bosselut

Affiliations

  1. Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  2. David H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY.
  3. Immunology Graduate Group, University of Pennsylvania Medical School, Philadelphia, PA.
  4. Viral Immunology and Intravital Imaging Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
  5. Single Cell Analysis Facility, Cancer Research Technology Program, Frederick National Laboratory, Bethesda, MD.

PMID: 34792530 PMCID: PMC8605495 DOI: 10.1084/jem.20202343

Abstract

During the immune response, CD4+ T cells differentiate into distinct effector subtypes, including follicular helper T (Tfh) cells that help B cells, and into memory cells. Tfh and memory cells are required for long-term immunity; both depend on the transcription factor Bcl6, raising the question whether they differentiate through similar mechanisms. Here, using single-cell RNA and ATAC sequencing, we show that virus-responding CD4+ T cells lacking both Bcl6 and Blimp1 can differentiate into cells with transcriptomic, chromatin accessibility, and functional attributes of memory cells but not of Tfh cells. Thus, Bcl6 promotes memory cell differentiation primarily through its repression of Blimp1. These findings demonstrate that distinct mechanisms underpin the differentiation of memory and Tfh CD4+ cells and define the Bcl6-Blimp1 axis as a potential target for promoting long-term memory T cell differentiation.

This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

Conflict of interest statement

Disclosures: The authors declare no competing interests exist.

References

  1. Nature. 1999 Oct 14;401(6754):708-12 - PubMed
  2. Int Immunol. 2007 Apr;19(4):427-33 - PubMed
  3. Cell Rep. 2017 Jul 25;20(4):806-818 - PubMed
  4. Nat Rev Immunol. 2016 Feb;16(2):102-11 - PubMed
  5. Sci Immunol. 2020 Mar 6;5(45): - PubMed
  6. Science. 2016 Jan 29;351(6272):511-4 - PubMed
  7. Nat Commun. 2017 Jan 16;8:14049 - PubMed
  8. Nat Immunol. 2011 Jun;12(6):467-71 - PubMed
  9. Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):13236-13241 - PubMed
  10. Cold Spring Harb Perspect Biol. 2018 Mar 1;10(3): - PubMed
  11. Immunity. 2019 Jan 15;50(1):91-105.e4 - PubMed
  12. Immunity. 2009 Aug 21;31(2):309-20 - PubMed
  13. Nat Immunol. 2015 Sep;16(9):991-9 - PubMed
  14. Nat Med. 2001 Aug;7(8):913-9 - PubMed
  15. Nat Immunol. 2020 Jul;21(7):777-789 - PubMed
  16. Cell Rep. 2015 Sep 29;12(12):2099-110 - PubMed
  17. Semin Immunol. 2009 Apr;21(2):53-61 - PubMed
  18. J Exp Med. 2017 Jan;214(1):39-47 - PubMed
  19. Science. 2009 Aug 21;325(5943):1001-5 - PubMed
  20. Immunity. 2011 Oct 28;35(4):583-95 - PubMed
  21. Science. 2016 Apr 22;352(6284):459-63 - PubMed
  22. Nat Immunol. 2015 Sep;16(9):980-90 - PubMed
  23. J Exp Med. 2015 Apr 6;212(4):539-53 - PubMed
  24. Nat Rev Immunol. 2012 Jan 20;12(2):136-48 - PubMed
  25. Cell Rep. 2016 Feb 23;14(7):1735-1747 - PubMed
  26. Nat Immunol. 2006 May;7(5):466-74 - PubMed
  27. Science. 2009 Aug 21;325(5943):1006-10 - PubMed
  28. Immunity. 2017 Apr 18;46(4):596-608 - PubMed
  29. J Infect Dis. 2014 Dec 15;210(12):1928-37 - PubMed
  30. Eur J Immunol. 1998 Jan;28(1):390-400 - PubMed
  31. Science. 2018 Sep 14;361(6407): - PubMed
  32. Immunity. 2011 Oct 28;35(4):633-46 - PubMed
  33. Science. 2013 May 3;340(6132):630-5 - PubMed
  34. Curr Top Microbiol Immunol. 2002;263:83-117 - PubMed
  35. Immunity. 2009 Sep 18;31(3):457-68 - PubMed
  36. Immunity. 2009 Aug 21;31(2):296-308 - PubMed
  37. Nat Rev Immunol. 2020 Nov;20(11):709-713 - PubMed
  38. Genesis. 2012 Dec;50(12):908-13 - PubMed
  39. Cytometry A. 2014 Jul;85(7):621-7 - PubMed
  40. Nat Immunol. 2010 Feb;11(2):114-20 - PubMed
  41. BMC Dev Biol. 2001;1:4 - PubMed
  42. J Immunol. 2013 Oct 1;191(7):3705-11 - PubMed
  43. Nature. 2008 Mar 20;452(7185):356-60 - PubMed
  44. Science. 2018 Jan 12;359(6372):177-186 - PubMed
  45. Eur J Immunol. 2017 Jul;47(7):1136-1141 - PubMed
  46. Cell. 2019 Jun 13;177(7):1888-1902.e21 - PubMed
  47. J Immunol. 2009 Apr 15;182(8):4581-9 - PubMed
  48. Immunity. 2003 Oct;19(4):607-20 - PubMed
  49. Nat Immunol. 2006 May;7(5):457-65 - PubMed
  50. Nat Immunol. 2004 Nov;5(11):1157-65 - PubMed
  51. J Immunol. 2013 Apr 15;190(8):4014-26 - PubMed
  52. Immunity. 2014 Feb 20;40(2):289-302 - PubMed

Publication Types

Grant support